FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2565697939> ?p ?o ?g. }

• W2565697939 abstract "Background. Appendiceal peritoneal pseudomyxoma (PMP) is very rare disease and its longterm prognosis is poor. The aim of this study was to evaluate the results of an aggressive treatment approach used in our institution for the last 4 years. Methods. We selected all patients with PMP from appendiceal origin who were treated by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) at the Klaipeda University Hospital between January 2012 and January 2016. Data from all patients with PMP arising from the appendix were retrospectively collected and analyzed. Treatment consisted of complete surgical cytoreduction , followed by hyperthermic intraperitoneal chemotherapy with mitomycin at 42°C over 90 minutes. Ronnett’s hystologic classification was used for tumor grading. Results. A total of 6 patients underwent cytoreduction and peritonectomy plus HIPEC. Median age at diagnosis was 57 years (range, 39-67). All our patients were female. The previous surgery score at the moment of admission was PSS-2 for three patients, PSS-3 for 3 patients. Four patients were diagnosed as diffuse peritoneal adenomucinosis (DRAM) and two as peritoneal mucinous carcinomatosis( PMCA). In all of the patients, optimal cytoreduction CC-0 (5 patients) and CC-1 (one patient) was achieved. The median peritoneal cancer index (PCI) was 17 (range, 14-25) as an indicator of disease extension.The median number of visceral resections performed per patient was 3 (range, 1-5). The median duration of CRS/HIPEC was 8 hours and 10 minutes (range, 7 hours and10 min. to 9 hours 20 min). Mean postoperative stay was 13 days (range, 8-18). The 30 days postoperative and in-hospital mortality were zero . One patient experienced temporary haemorhagic cystitis. The mean follow-up period was 28 months ( range, 8-45). At the time of analysis all patients are alive and without recurrence. Conclusions PMP from appendiceal origin can be treated with curative intent in a large percentage of cases by cytoreductive surgery associated with HIPEC. This new approach could be performed safely with acceptable morbidity and mortality in selected patients treated in specialized centers." @default.
• W2565697939 created "2017-01-06" @default.
• W2565697939 creator A5004177291 @default.
• W2565697939 creator A5039389466 @default.
• W2565697939 creator A5040392629 @default.
• W2565697939 creator A5058451313 @default.
• W2565697939 date "2016-12-22" @default.
• W2565697939 modified "2023-09-25" @default.
• W2565697939 title "Early Data Of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated By A Strategy Of Cytoreductive Surgery And Hyperthermic Intraperitoneal Chemotherapy" @default.
• W2565697939 cites W17791541 @default.
• W2565697939 cites W1928450008 @default.
• W2565697939 cites W1959566031 @default.
• W2565697939 cites W1981380097 @default.
• W2565697939 cites W1982610093 @default.
• W2565697939 cites W2000447039 @default.
• W2565697939 cites W2046167203 @default.
• W2565697939 cites W2047169143 @default.
• W2565697939 cites W2097198751 @default.
• W2565697939 cites W2172143618 @default.
• W2565697939 doi "https://doi.org/10.5200/sm-hs.2016.078" @default.
• W2565697939 hasPublicationYear "2016" @default.
• W2565697939 type Work @default.
• W2565697939 sameAs 2565697939 @default.
• W2565697939 citedByCount "0" @default.
• W2565697939 crossrefType "journal-article" @default.
• W2565697939 hasAuthorship W2565697939A5004177291 @default.
• W2565697939 hasAuthorship W2565697939A5039389466 @default.
• W2565697939 hasAuthorship W2565697939A5040392629 @default.
• W2565697939 hasAuthorship W2565697939A5058451313 @default.
• W2565697939 hasBestOaLocation W25656979391 @default.
• W2565697939 hasConcept C121608353 @default.
• W2565697939 hasConcept C126322002 @default.
• W2565697939 hasConcept C141071460 @default.
• W2565697939 hasConcept C151730666 @default.
• W2565697939 hasConcept C2776364125 @default.
• W2565697939 hasConcept C2779458272 @default.
• W2565697939 hasConcept C2780427987 @default.
• W2565697939 hasConcept C2780898957 @default.
• W2565697939 hasConcept C2994223192 @default.
• W2565697939 hasConcept C45393284 @default.
• W2565697939 hasConcept C500558357 @default.
• W2565697939 hasConcept C71924100 @default.
• W2565697939 hasConcept C86803240 @default.
• W2565697939 hasConceptScore W2565697939C121608353 @default.
• W2565697939 hasConceptScore W2565697939C126322002 @default.
• W2565697939 hasConceptScore W2565697939C141071460 @default.
• W2565697939 hasConceptScore W2565697939C151730666 @default.
• W2565697939 hasConceptScore W2565697939C2776364125 @default.
• W2565697939 hasConceptScore W2565697939C2779458272 @default.
• W2565697939 hasConceptScore W2565697939C2780427987 @default.
• W2565697939 hasConceptScore W2565697939C2780898957 @default.
• W2565697939 hasConceptScore W2565697939C2994223192 @default.
• W2565697939 hasConceptScore W2565697939C45393284 @default.
• W2565697939 hasConceptScore W2565697939C500558357 @default.
• W2565697939 hasConceptScore W2565697939C71924100 @default.
• W2565697939 hasConceptScore W2565697939C86803240 @default.
• W2565697939 hasLocation W25656979391 @default.
• W2565697939 hasOpenAccess W2565697939 @default.
• W2565697939 hasPrimaryLocation W25656979391 @default.
• W2565697939 isParatext "false" @default.
• W2565697939 isRetracted "false" @default.
• W2565697939 magId "2565697939" @default.
• W2565697939 workType "article" @default.